Oruka Therapeutics, Inc.
Biotechnology
Healthcare
ORKA
41.68 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
17.21
52 week high
30.49
high
17.44
52 week low
0.00
low
15.50
growth
-37.76 %
previous Close
17.15
P/E ratio
market cap
522 M
div yield
0
net incoming
-24.57 M
0.00 %
net profit margin
-2457400000.00 %
0.00 %
operating incoming
-28.43 M
0.00 %
net change in cash
-18.18 M
0.00 %
cash on hand
65.40 M
0.00 %
top